SEC Form D private-offering filing

MAIA Biotechnology, Inc.

Name: MAIA Biotechnology, Inc. - new SEC Form D private-offering filing, Chicago, IL
Published: 2026-01-05

A new SEC Form D private-offering notice from Chicago, IL, a $2,000,000 filer-stated offering target in Biotech. The source filing is one click away.

MAIA Biotechnology, Inc. site↗ Verified via SEC Form D

Clinical stage immuno-oncology company developing ateganosine (THIO), a telomere targeting cancer therapy, publicly traded on NYSE American.

Filed 2026-01-05Filed to raise $2,000,000First money in 2025-12-22Raised so far $1,509,789HQ (as filed) Chicago, ILSector Biotech ✓Stage (inferred) SeedCall status Needs classification

Source linked the Form D on EDGAR↗Website verified maiabiotech.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Illinois →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.